NFXDG | 1369320-98-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: NFXDG
• 英文别名: 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid 2-hexadecanoyloxy-1-hexadecanoyloxymethyl-ethyl ester
• CAS: 1369320-98-8
• 化学式: C₅₁H₈₄FN₃O₇
• 分子量: 870.242
• InChiKey: NVOGLIMLHWTGST-UHFFFAOYSA-N

物化性质

• 沸点：
  840.8±65.0 °C(Predicted)
• 密度：
  1.046±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  12.14
• 重原子数：
  62.0
• 可旋转键数：
  36.0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.76
• 拓扑面积：
  116.17
• 氢给体数：
  1.0
• 氢受体数：
  10.0

反应信息

• 作为反应物：
  描述：

  NFXDG 在 lipase 作用下， 反应 10.0h， 以32%的产率得到诺氟沙星
  参考文献：
  名称：

  Diglyceride prodrug strategy for enhancing the bioavailability of norfloxacin

  摘要：

  Prodrug approach using diglyceride as a promoiety is a promising strategy to improve bioavailability of poorly absorbed drugs and the same was explored in the present work to improve oral bioavailability of norfloxacin: a second generation fluoroquinolone antibacterial. The prodrug was synthesized by standard procedures using dipalmitine as a carrier and the structure was confirmed by spectral analysis. Higher Log P indicated improved lipophilicity. The ester linkage between norfloxacin and dipalmitine would be susceptible to hydrolysis by lipases to release the parent drug and carrier in the body. In vivo kinetic studies in rats indicated 53% release of norfloxacin in plasma at the end of 8 h. The prodrug exhibited improved pharmacological profile than the parent compound at equimolar dose that indirectly indicated improved bioavailability. (C) 2011 Elsevier Ireland Ltd. All rights reserved.

  DOI：

  10.1016/j.chemphyslip.2011.03.006
• 作为产物：
  描述：

  棕榈酰氯 在 吡啶 、 sodium tetrahydroborate 、 三甲基溴硅烷 作用下， 以 四氢呋喃 、 二氯甲烷 、 氯仿 、 水 、 苯 为溶剂， 反应 43.5h， 生成 NFXDG
  参考文献：
  名称：

  Diglyceride prodrug strategy for enhancing the bioavailability of norfloxacin

  摘要：

  Prodrug approach using diglyceride as a promoiety is a promising strategy to improve bioavailability of poorly absorbed drugs and the same was explored in the present work to improve oral bioavailability of norfloxacin: a second generation fluoroquinolone antibacterial. The prodrug was synthesized by standard procedures using dipalmitine as a carrier and the structure was confirmed by spectral analysis. Higher Log P indicated improved lipophilicity. The ester linkage between norfloxacin and dipalmitine would be susceptible to hydrolysis by lipases to release the parent drug and carrier in the body. In vivo kinetic studies in rats indicated 53% release of norfloxacin in plasma at the end of 8 h. The prodrug exhibited improved pharmacological profile than the parent compound at equimolar dose that indirectly indicated improved bioavailability. (C) 2011 Elsevier Ireland Ltd. All rights reserved.

  DOI：

  10.1016/j.chemphyslip.2011.03.006